Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer

PURPOSE: To investigate the differences in prostate-specific antigen (PSA) bounce (PB) after high-dose-rate (HDR-BT) or low-dose-rate (LDR-BT) brachytherapy alone in prostate cancer patients. MATERIALS AND METHODS: Ninety-four patients with localized prostate cancer (T1-T2cN0), age ranged 50-81 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Burchardt, Wojciech, Skowronek, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881590/
https://www.ncbi.nlm.nih.gov/pubmed/29619050
http://dx.doi.org/10.5114/jcb.2018.73786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881590/
https://www.ncbi.nlm.nih.gov/pubmed/29619050
http://dx.doi.org/10.5114/jcb.2018.73786

Ejemplares similares